John Tsai, the worldwide team leader for Lipitor, argues that Lipitor's efficacy may save insurers cost in the long run, and that his drug clearly provides a benefit over standard of care.

FORBES: Magazine Article

Unless we come up with long-term solutions to grow the American economy, create more jobs and maintain our standard of living, we run the risk of a societal meltdown.

FORBES: Reviving America's Economy: 3 Issues We Need To Address Now